In contrast to CFA, we did not observe a significant decrease in CFM in 14‐month 5XFAD control AAV animals compared to Ntg controls, suggesting that DLGAP2 overexpression accelerates AD‐related impairment of CFM at 14 months of age. The gene discussed is DLGAP2; the disease is Alzheimer disease.